PSYCHEMEDICS CORP Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Psychemedics Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Psychemedics Corp Operating Income (Loss) for the quarter ending June 30, 2024 was -$899K, a 116% decline year-over-year.
  • Psychemedics Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was -$3.44M, a 105% decline year-over-year.
  • Psychemedics Corp annual Operating Income (Loss) for 2023 was -$2.92M, a 170% decline from 2022.
  • Psychemedics Corp annual Operating Income (Loss) for 2022 was -$1.08M, a 618% decline from 2021.
  • Psychemedics Corp annual Operating Income (Loss) for 2021 was $209K.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$3.44M -$899K -$482K -116% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$2.96M -$567K -$39K -7.39% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$2.92M -$869K -$513K -144% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$2.41M -$1.11M -$732K -195% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$1.68M -$417K -$75K -21.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$1.6M -$528K -$518K -5180% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$1.08M -$356K +$609K +63.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$1.69M -$375K -$1.23M -144% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$467K -$342K -$549K -265% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $82K -$10K -$127K -109% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $209K -$965K +$144K +13% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $65K $850K +$2.26M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$2.19M $207K +$3.51M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$5.71M $117K +$359K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$6.07M -$1.11M -$503K -83% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-26
Q3 2020 -$5.56M -$1.41M -$2.74M -206% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.82M -$3.31M -$4.63M -349% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.81M -$242K -$1.19M -126% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $3M -$606K -$2.13M -140% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 $5.13M $1.33M -$786K -37.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-26
Q2 2019 $5.92M $1.33M -$730K -35.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-26
Q1 2019 $6.65M $944K -$962K -50.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-26
Q4 2018 $7.61M $1.53M -$419K -21.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-25
Q3 2018 $8.03M $2.12M -$112K -5.02% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-25
Q2 2018 $8.14M $2.06M +$346K +20.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-25
Q1 2018 $7.8M $1.91M -$362K -16% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-25
Q4 2017 $8.16M $1.95M -$1.69M -46.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-04
Q3 2017 $9.85M $2.23M -$1.87M -45.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-04
Q2 2017 $11.7M $1.71M -$661K -27.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-04
Q1 2017 $12.4M $2.27M +$2.27M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-04
Q4 2016 $10.1M $3.64M +$3.52M +3090% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $6.59M $4.1M +$3.55M +646% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 $3.03M $2.37M +$2.02M +566% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 $1.02M -$2K* -$453K Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 $1.47M $114K -$844K -88.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-07
Q3 2015 $2.32M $550K -$694K -55.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-07
Q2 2015 $3.01M $356K -$964K -73% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-07
Q1 2015 $3.97M $451K -$717K -61.4% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-07
Q4 2014 $4.69M $958K -$75K -7.26% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 $4.77M $1.24M -$495K -28.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 $5.26M $1.32M -$412K -23.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 $5.67M $1.17M -$34K -2.83% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q4 2013 $5.71M $1.03M +$569K +123% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 $5.14M $1.74M +$308K +21.5% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-27
Q2 2013 $4.83M $1.73M +$67.9K +4.08% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-27
Q1 2013 $4.76M $1.2M -$175K -12.7% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-27
Q4 2012 $4.94M $464K -$282K -37.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 $5.22M $1.43M -$377K -20.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-28
Q2 2012 $5.6M $1.66M -$93.8K -5.34% Mar 31, 2012 Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $5.69M $1.38M -$113K -7.58% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-28
Q4 2011 $5.8M $746K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-08
Q3 2011 $1.81M +$472K +35.3% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-08
Q2 2011 $1.76M +$194K +12.4% Mar 31, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $1.49M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-08
Q3 2010 $1.34M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $1.56M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.